Full read BMJ ovverview of PMR - PMR Clinically recognized 1957 - Is it a uniquie vs overlap entity - Is there subclinical GCA in PMR? - Is PMR for PCPs? https://t.co/0BKGdt5Kxf https://t.co/sfAZoYyVan

ICYMI: How early is early in PsA? Guidelines for the management of PsA recommend the early referral of patients with the suspected condition for early assessment and treatment. https://t.co/AAZegiV6OL https://t.co/v5jIsPjX0c

Subtype of dermatomyositis is positive for Melanoma differentiation-associated protein 5 (MDA5) antibody. This poor prognosis subtype has distinctive rashes, rapidly progressive interstitial lung disease, lymphopenia &elevated ferritin levels https://t.co/FJjdO27cQQ https://t.co/gis2aWOLa7

Early bird pricing has been extended! Register today! https://t.co/BysC0RunUh https://t.co/4Ar0kHa4tt

Palmoplantar pustulosis (PPP) is difficult to treat; w/ few reports of JAKi efficacy. Now a report of 21 PPP pts given bimekizumab and 17 patients showed complete clearance in 1 to 4 months. SAPHO pts had complete clearance of skin & improved joint pain https://t.co/tYpHCxFOBI https://t.co/i4o3KnGlPY

UK Dermatology Registry of 13 699 Psoriasis pts on biologics (25K biologic exposures) found 1% risk of paradoxical eczema. Biologics included inhibitors of TNF, IL-17, IL12/23, IL-23. Lowest risk w/ IL-23i (0.56/100kPY), and higher w/ IL-17i (1.22) https://t.co/fOX6VGJQLk https://t.co/u1p1sidCte

Post-Menopausal Osteoporosis Review and Recommendations A recent New England Journal review of post-menopausal osteoporosis (OP) provided updated information, strategies and a review of guidelines and clinical recommendations. https://t.co/TkJjsX98Ww https://t.co/2Hi72GjEHM

ICYMI: The Heart of Lupus Few people are aware of the EULAR recommendations1 for cardiovascular (CV) risk management in systemic lupus erythematosus (SLE) published in 2022. The recommendations had 4 overarching principles... https://t.co/5I5eYNqHIu https://t.co/W6VzUFs6kN

Withdraw DMARDS after remission? Considering withdrawing DMARDs after remission is on our minds. When patients inquire about tapering or stopping DMARDs while doing well, we often lack a clear-cut answer. https://t.co/wqcCff7kjx https://t.co/vq9ee1dZNX

Calcineurin Inhibitors in Lupus Nephritis Dr. Kathryn Dao discusses abstract 1509 with Dr. Gabriel Figueroa-Parra at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/1sjvCUyvD9 https://t.co/kocmtM1j6o

Pneumocystis Jiroveci Pneumonia (PJP) Risk https://t.co/OTG9Ud1adu https://t.co/jIhdwws0Un

ICYMI: Are Rheumatologists doing Enough for Cervical Cancer? https://t.co/afg5YL3RCN https://t.co/VRyKh6VgmS